Harald Wajant
Works:
- Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling
- Tumor necrosis factor receptor 2 (TNFR2): an emerging target in cancer therapy
- Das Adapterprotein TRAF2 und seine Bedeutung für die Todesrezeptor-vermittelte Signaltransduktion
- TNF receptor associated factor 2 (TRAF2) signaling in cancer